Mona Chetan Patel - 11 Jun 2025 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Mona Chetan Patel pursuant to Power of Attorney previously filed.
Issuer symbol: COCH
Transactions as of: 11 Jun 2025
Net transactions value: +$3,675
Form type: 4
Filing time: 13 Jun 2025, 16:10:30 UTC
Previous filing: 10 Jun 2025
Next filing: 05 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Patel Mona Chetan	Director	C/O 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE	/s/ Andrew Nick as Attorney-in-Fact for Mona Chetan Patel pursuant to Power of Attorney previously filed.	13 Jun 2025	0001995769

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COCH	Class A Common Stock	Purchase	$3,675	+2,500	+14%	$1.47	20,000	11 Jun 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	COCH	Stock Option (right to buy)						25,000	11 Jun 2025	Class A Common Stock	25,000	$2.40	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.4799 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.4799 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.